Skip to content
Wenlo
Sign in
← Markets

Aytu BioPharma, Inc.

Aytu BioPharma, Inc. (AYTU) — Form 8-K: Current report

8-KAYTUFiled Nov 16, 2026, 11:03 AM ET· Period Nov 16, 2026

About this filing

Aytu BioPharma, Inc. (AYTU) filed an 8-K on Nov 16, 2026 reporting entry into a material agreement (Item 1.01) and a Regulation FD disclosure (Item 7.01), with exhibits (Item 9.01).

Key facts

  • Item 1.01 · Entry into a material agreement
  • Item 7.01 · Regulation FD disclosure
  • Item 9.01 · Financial statements and exhibits

More AYTU filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.